Cipralex vs. Citalopram

Cipralex demonstrates better efficacy, higher rates of response and remission and faster time to symptom relief.

MADRS total score, mean change from baseline (ITT) (ref.1)

Cipralex has consistently demontrated to be more effective and have a faster onset of action compared to citalopram
* p< 0.05 vs. placebo
** p< 0.01 vs. placebo
# p< 0.05 vs. citalopram
## p< 0.01 vs. citalopram
  • Superior efficacy compared with citalopram has been shown in individual studies, pooled- and meta-analyses. Escitalopram 10–20 mg/day was more effective than citalopram 20–40 mg/day in reducing the symptoms of depression and provided more rapid relief. The observed differences were particularly pronounced in severely ill patients.

Percentage of patients (ref.2)

Proportion of responders (patients with =>50% reduction of baseline MADRS score) and remitters (proportion of patients with a MADRS score of =<12) at week 8 (LOCF analysis) from a study of patients with major depressive disorder treated with 10–20 mg/day escitalopram or 20–40 mg/day citalopram (intention-to-treat population).
# Significantly different from citalopram, p<0.05
  • Clinical studies have consistently shown superior response and remission rates with Cipralex vs. citalopram.

References:

1. Llorca et al. int J Clin Pract 2005;59:268-75

2. Lepola et al., 2003

Last updated: 03.05.2006